Medical Devices

Interventional cardiology: How MedTech is reducing premature mortality caused by cardiovascular diseases

<!----> Cardiovascular diseases are a group of disorders affecting the heart, conduction system, and blood vessels. The underlying...

Top News

Health Canada authorises bioLytical’s syphilis antibody test

<!----> Health Canada has granted authorisation to in-vitro medical diagnostics provider bioLytical Laboratories for its INSTI multiplex HIV-1/2...

Q’Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter

FREMONT, CA / ACCESSWIRE / March 28, 2023 / Q'Apel Medical Inc. was granted the CE Mark under MDR for Walrus, their U.S. market-leading...

Illumina and GenoScreen introduce new tuberculosis test

<!----> Biotechnology firm Illumina and genomics company GenoScreen have introduced a new package that combines products from Illumina...

Revised PLI Norms for Medical Device Projects

SEO Powered Content & PR...

Biocept begins subject enrolment in CNSide assay trial

<!----> Molecular diagnostic assays provider Biocept has enrolled the first participant in the FORESEE clinical trial for CNSide,...

Vaporox Announces FDA Clearance for Its Next Generation Wound Care Medical Device

DENVER, March 27, 2023 (GLOBE NEWSWIRE) -- Vaporox, a Denver based medical device company, has received clearance from the US Food and Drug Administration...

INVO Bioscience Announces Closing of $3.0 Million Registered Direct Offering

SARASOTA, Fla., March 27, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access...

NeuroRPM receives clearance from FDA for Parkinson’s monitoring app

<!----> Digital health company NeuroRPM has received clearance from the US Food and Drug Administration (FDA) for its...

Askel to commercialise COPLA implant in US and EU by 2028

<!----> Finnish medical technology company Askel Healthcare has announced that it aims to commercialise its COPLA implant, developed...

Eversana to support ChemoMouthpiece device launch in US

<!----> Eversana has announced a collaboration with ChemoMouthpiece to support the US launch and commercialisation of the latter’s...

Innovation Devices Exempted from DRG in China

The National Health Insurance Administration issued the “Reply to Recommendation No. 3298 of National People’s Congress” on March 4, in which the Administration agrees...

INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market

  SARASOTA, Fla., March 24, 2023 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on...

Latest Intelligence